Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Foukas Joshua

2. Date of Event Requiring Statement (MM/DD/YYYY) 7/24/2018

3. Issuer Name and Ticker or Trading Symbol

USANA HEALTH SCIENCES INC [USNA]

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Chief Legal Officer /

(Street)

SALT LAKE CITY 84120

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	306	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock - Settles Stock Appreciation Right	9/1/2017 ⁽¹⁾	3/1/2020	Common Stock	30000	$70.745	D
Restricted Stock Units	⁽²⁾	⁽²⁾	Common Stock	1293 ⁽⁶⁾	$0	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock	1261 ⁽⁶⁾	$0	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	2892 ⁽⁶⁾	$0	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock	1726 ⁽⁶⁾	$0	D

Explanation of Responses:
(1)	Stock-Settled Stock Appreciation Rights vest 40% on the second anniversary of the grant date, 30% on the third anniversary of the grant date, and 30% on the fourth anniversary of the grant date.
(2)	On May 1st, 2017, the reporting person was granted 1,723 restricted stock units, vesting at 25% on each 6th of February thereafter.
(3)	On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on the anniversary of the grant date.
(4)	On February 5th, 2018, the reporting person was granted 2,892 restricted stock units, vesting at 25% on the anniversary of the grant date.
(5)	On July 23rd, 2018, the reporting person was granted 1,726 restricted stock units, vesting at 25% on the anniversary of the grant date.
(6)	Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Foukas Joshua 3838 WEST PARKWAY BLVD. SALT LAKE CITY 84120			Chief Legal Officer

Signatures
Joshua Foukas		8/3/2018
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.